1. Home
  2. Labeler Index
  3. Ge Healthcare Inc.
  4. 72874-001
  5. NDC Package Code: 72874-001-01 Cerianna

NDC Package 72874-001-01 Cerianna

Fluoroestradiol F 18 Injection Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
72874-001-01
Package Description:
50 mL in 1 VIAL, MULTI-DOSE
Product Code:
72874-001
Proprietary Name:
Cerianna
Non-Proprietary Name:
Fluoroestradiol F 18
Substance Name:
Fluoroestradiol F-18
Usage Information:
CERIANNA is indicated for use with positron emission tomography (PET imaging) for characterization of estrogen receptor (ER) status of known or suspected metastatic lesions in patients with confirmed ER-positive breast cancer.Limitations of UseTissue biopsy should be used to confirm recurrence of breast cancer and to verify ER status by pathology.  CERIANNA is not useful for imaigng other receptors, such as human epidermal growth factor receptor 2 (HER2) and the progesterone receptor (PR)
11-Digit NDC Billing Format:
72874000101
Product Type:
Human Prescription Drug
Labeler Name:
Ge Healthcare Inc.
Dosage Form:
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • FLUOROESTRADIOL F-18 100 mCi/mL
    • Pharmacologic Class(es):
  • Positron Emitting Activity - [MoA] (Mechanism of Action)
  • Radioactive Diagnostic Agent - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    NDA212155
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    05-20-2020
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 72874-001-01?

    The NDC Packaged Code 72874-001-01 is assigned to a package of 50 ml in 1 vial, multi-dose of Cerianna, a human prescription drug labeled by Ge Healthcare Inc.. The product's dosage form is injection and is administered via intravenous form.

    Is NDC 72874-001 included in the NDC Directory?

    Yes, Cerianna with product code 72874-001 is active and included in the NDC Directory. The product was first marketed by Ge Healthcare Inc. on May 20, 2020 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 72874-001-01?

    The 11-digit format is 72874000101. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-272874-001-015-4-272874-0001-01